SUBSCRIBE
SUBSCRIBE

Cosette Pharmaceuticals

JOBS
IN THE PRESS
Pharm Country
Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 Million
December 20, 2023
 · 
5 min read
Pharm Country
Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable
October 3, 2023
 · 
5 min read
FDA
Cosette Pharmaceuticals Launches Metronidazole Vaginal Gel 0.75%, AB-rated to MetroGel-Vaginal® 0.75%
July 27, 2023
 · 
2 min read
Pharm Country
Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5%
July 13, 2023
 · 
2 min read
Deals
Cosette Pharmaceuticals Acquires Intrarosa® from Endoceutics, Inc.
June 8, 2023
 · 
2 min read
Pharm Country
Cosette Pharmaceuticals Launches Betaine Anhydrous Powder, AB-rated to Cystadane® (betaine anhydrous for oral solution)
March 2, 2023
 · 
2 min read
FDA
Cosette Pharmaceuticals Announces the Approval and Launch of Metronidazole Gel USP, 1%
February 9, 2023
 · 
2 min read
Pharm Country
Cosette Pharmaceuticals Announces the launch of Griseofulvin Oral Suspension, 125 mg/5 mL.
December 6, 2022
 · 
2 min read
Business
Cosette Pharmaceuticals Appoints Kevin Hickey, Vice President, Brand Sales and Marketing to Accelerate Transformation
November 17, 2022
 · 
3 min read
FDA
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Versions of TAZORAC® (tazarotene) gel, 0.05% and 0.1%, with 180 days Competitive Generic Therapy (CGT) exclusivity
September 20, 2022
 · 
2 min read
Load More